Skip to main content
. 2019 May 22;2019:2741598. doi: 10.1155/2019/2741598

Table 1.

Model input parameters.

Parameter Expected value (SD) Source
Progression
 Normal → BCH/mD β 0 = -8.96 (0.461) Derived from calibration
β 1 = 0.20481 (0.01815)
β 2 = 0.00002 (0)
β 3 = 0.00836 (0.00134)
 BCH/mD → MD α 0 = -3.359 (0.171) Derived from calibration
α 1 = 0.03668 (0.0095)
 MD → SD 15.38% Derived from calibration
 SD → Undetected ESCC (TNM I) 20.94% [9]
 Undetected ESCC (TNM I) → Undetected ESCC (TNM II) 15.38% Derived from calibration
 Undetected ESCC (TNM II) → Undetected ESCC (TNM III) 20.94% Derived from calibration
 Undetected ESCC (TNM III) → Undetected ESCC (TNM IV) 46.65% Derived from calibration
Detection rate
 Undetected ESCC (TNM I) → Detected ESCC (TNM I) 54.87% Derived from calibration
 Undetected ESCC (TNM II) → Detected ESCC (TNM II) 32.31% Derived from calibration
 Undetected ESCC (TNM III) → Detected ESCC (TNM III) 3.86% Derived from calibration
 Undetected ESCC (TNM IV) → Detected ESCC (TNM IV) 34.32% Derived from calibration
Mortality
 All-cause mortality Chinese life-table [10]
 Disease-specific mortality (TNM I) Chinese life-table [10]
 Disease-specific mortality (TNM II) 15.15% [11, 12]
 Disease-specific mortality (TNM III) 35.97% [11, 12]
 Disease-specific mortality (TNM IV) 56.47% [11, 12]

It was assumed to be equivalent with normal population after complete resection.

ESCC, esophageal squamous cell carcinoma; BCH, basal cell hyperplasia; mD, mild dysplasia; MD, moderate dysplasia; SD, severe dysplasia.